Summary• Infection with PRRSV decreased pig
performance.
• PRRSV increased rectal temperature (d 3
to 10 PI).
• PRRSV increased lymphocytes (d 7 & 42
PI) and neutrophils (d 7 PI), but decreased
macrophages (d 7 PI).
• PRRSV increased subsets of lymphocytes
and T cells.
• ACT enhanced feed efficiency (d 28 to
42 PI) and PRRSV-specific antibodies in
infected pigs (d 35 PI).
• ACT increased rectal temperature.
• ACT increased leukocytes, lymphocytes,
and neutrophils in infected pigs (d 7 PI).
• ACT increased subsets of lymphocytes and
T cells in infected pigs (d 7 PI).
ConclusionThese findings confirm that Actigen™ strengthens
immune response and efficiency in the face of a
PRRSV challenge.
Acknowledgments
The authors gratefully thank Alltech, Inc. for
supporting this research.
Introduction• Mannan-containing products have been
shown to affect innate and adaptive
immunity in animals. Different products may
have diverse immunomodulatory effects.
• Therefore, evaluation of effects of Actigen™
(ACT, a refined yeast-based mannan
preparation, Alltech, Inc.) on immune
responses of pigs under disease-challenged
conditions is needed.
Objective• To test whether feeding ACT alters
immune responses in pigs experimentally
infected with porcine reproductive and
respiratory syndrome virus (PRRSV)
Materials and MethodsAnimals, experimental design, & feeding:• Weaned pigs (n = 64, 32 gilts and 32
barrows), 21 d old, free of PRRSV
• RCBD, 2 x 2 factorial arrangement, blocks
(initial BW within sex)
• Factors: diet (control & 0.04% ACT), PRRSV
(with & without)
• 4-phase feeding program with declining
diet complexity
Experimental procedures:
Measurements: • Pig performance: ADG, ADFI, and G:F
• Rectal temperature (RT) at d 0, 3, 7
postinoculation (PI) and weekly until d 42 PI
• Viremia and antibodies in serum: at d 28, 0,
7, 21, and 35 PI
• Bronchoalveolar lavage (BAL) cells: at d 7
and 42 PI, flow cytometry technique
Statistical analysis: • RCBD, using MIXED procedure of SAS,
pigs as experimental units
• Rectal temperature: repeated measures
Results
Actigen™ improves growth efficiency and immune responses in pigs experimentally infected with PRRS virus��������������� ����������� ��� ����������������������������������������������� � ����!����"��#�����$��
1Department of Animal Sciences, University of Illinois, Urbana, IL, 2Animal Disease and Diagnostic Laboratory, Purdue University, West Lafayette, IN, and 3Alltech Inc., Nicholasville, KY
�������
����� �� ����
��������
����������
��������
����������
������������� � ��� ������
������������������� ��
��������������������� ������� ������������ ������ �� !��
����������� ������ �� !��"���#���$%&��'���'(�)*�"���� �#�������� ��������+��,
Table 1. Effects of Actigen™ and PRRSV on subpopulations of lymphocytes and T cells in BAL of pigs at d 7 PI
Cells in BAL Treatments (n = 8) P-value
Lymphocytes, x104/mL CON ACT ICON IACT SEM Diet PRRSV Interaction
T 22 19 42 77 13 NS < 0.02 < 0.08
B 4 4 8 23 4 NS < 0.02 < 0.08
Natural killer 10 9 18 43 5 < 0.02 < 0.001 < 0.01
T cell subsets, x104/mL
Naive 0.4 0.4 0.5 2.5 0.5 < 0.08 < 0.07 < 0.10
Memory/activated 1.8 1.9 4.7 10.4 1.2 < 0.05 < 0.001 < 0.05
Cytotoxic 17.0 14.0 26.0 59.0 8 NS < 0.02 < 0.05
������� 2.6 2.8 1.5 5.0 0.9 < 0.10 NS < 0.10
Table 2. Effects of Actigen™ and PRRSV on subpopulations of lymphocytes and T cells in BAL of pigs at d 42 PI
Cells in BAL Treatments (n = 8) P-value
Lymphocytes, x104/mL CON ACT ICON IACT SEM Diet PRRSV Interaction
T 121 133 394 529 89 NS < 0.01 NS
B 13 16 46 42 9 NS < 0.02 NS
Natural killer 44 54 165 192 31 NS < 0.001 NS
T cell subsets, x104/mL
Naive 9 8 12 17 4 NS NS NS
Memory/activated 23 27 41 62 14 NS < 0.07 NS
Cytotoxic 72 77 305 409 69 NS < 0.001 NS
������� 17 21 36 41 6 NS < 0.01 NS
Figure 1. Effects of Actigen™ and PRRSV on pig performance 6-wk PRRSV infection
��
����
����
����
�����
����
������� ������ � � ������
-".&���
"�/������ ������� ���
���� ���� ����� �����
������������������������������
���������������
��
����
�����
� ���
�����
�����
������� ������ � � ������
-"0�&���
"�/������ ������� ���
���� ���� ����� �����
������������������������������
������������
��
����
����
����
�����
����
������� ������ � � ������
.#0&��1��
"�/������ ������� ���
���� ���� ����� �����
�����������������������������������������������������������
Figure 3. Effects of Actigen™ and PRRSV on differential leukocyte counts in BAL of pigs at d 7 and 42 PI
��
��
��
��
���
��
�� !�"#�$� �#%&'�"#�$� ()"*�&')+�$� �� *�&'�,$�
*������$
2���� ��3-%&
4��'
� 1$%
*������$
2���� ��3-%&
4��'
� 1$%
���� ���� ����� �����
��
��
���
� �
���
���
�� !�"#�$� �#%&'�"#�$� ()"*�&')+�$� �� *�&'�,$�
���� ���� ����� �����
�������������-�����
-�����
����������
����������-���������
����������-����������
���������
���������
����������
Figure 4. Effects of Actigen™ and PRRSV on serum viremia and PRRSV-specific antibodies of infected pigs
��
��
� �
�.�
���
.� ��� ��
��$ �&�*
������
"�/������ ������� ���
"�/������ ������� ���
����� �����
����
����
�� �
����
����
����
.� ��� ��
-�� 2��
��&��1����
� ��
����� ��������������
��������
Figure 2. Effects of Actigen™ and PRRSV on rectal temperature of pigs during 6-wk PRRSV infection
� � �
�����
�����
�����
�����
�� �� .� ��� ��� ��� � � �� ���
���������$
��������&�5*�
"�/������ ������� ���
������������������
����������������������������/(�������
IntroductionMannan-containing products have been shown to affect innate and
adaptive immunity in animals. Different products may have diverse
immunomodulatory effects.
Therefore, evaluation of effects of Actigen™ (ACT,
a refined yeast-based mannan preparation, Alltech,
Inc.) on immune responses of pigs under disease-
challenged conditions is needed.
ObjectiveTo evaluate effects of ACT on peripheral blood
immune cells in pigs infected with porcine
reproductive and respiratory syndrome virus
(PRRSV)
Materials and Methods
Animals, experimental designs, & feeding:
• Weaned pigs (n = 64, 32 gilts and 32 barrows),
21 d old, free of PRRSV
• RCBD, 2 x 2 factorial arrangement, blocks
(initial BW within sex)
• Factors: diet (control & 0.04% ACT), PRRSV
(with & without)
• 4-phase feeding program with declining diet
complexity
Experimental procedures:
Measurement of peripheral blood immune cells:
• Differential counts, subsets of lymphocytes
and T cells
• At d 0, 3, 7 postinoculation (PI) and weekly
until d 42 PI
• 8 replicates per treatment, using flow
cytometry technique
Statistical analysis:
• Data were analyzed as repeated measures over
time using the MIXED procedure of SAS.
Effects of Actigen™ on peripheral blood immune cells in pigs experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV)T. M. CHE1, M. SONG1, R. W. JOHNSON1, K. W. KELLEY1, W. G. VAN ALSTINE2, K. A. DAWSON3, AND J. E. PETTIGREW1
1Department of Animal Sciences, University of Illinois, Urbana, IL, 2Animal Disease and Diagnostic Laboratory, Purdue University, West Lafayette, IN,
and 3Alltech Inc., Nicholasville, KY
6
66
66
6 6
6
'�
��
�'�
���
�'�
���
�'�
'� �� 7� �8� ��� �9� ��� 8��%��:��/���&�4��'�
� 1�$%
*;<�
-*)�
�*;<�
�-*)�
)��������:��/�������/$� ��/�����2�����
����������������������������)#���������������������)#�������������������
6
'�
��
8�
��
9�
�'�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
)������&�4��'�
� 1�$%
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
6
6
6
66
'�
��
��
��
8�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
3������&�4��'�
� 1�$%
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
66
6
6 6
�������������)#������������������
'='�
'=��
�='�
�=��
�='�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
<�������: ����������&�4��'�
� 1�$% ���������������
�)#�������������������
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
6 6
6 66
'�
��
��
��
8�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
)��/$� ��/�����2�����
<� ��)������&�4��'�
� 1�$%
�����������������)#������������������
*;<�
-*)�
�*;<�
�-*)�6
66
6
6
66 6
6
'�
��
��
��
8�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
6
6 66
6>�$
��/1��� �����)������&
4��'
��1�$
%
�����������������)#�������������������
'�
��
��
��
8�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
*;<�
-*)�
�*;<�
�-*)�6
6
66
6
6
6
6 6
*/����4 ��)������&�4��'�
� 1�$%
������������0����������������)#�������������������
'�
��
��
��
8�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
*;<�
-*)�
�*;<�
�-*)�6
6
6
6 6
6
6
6 6
γ δ�)������&�4��'�
� 1�$%
������������������������������)#�����������������
�������
����� �� ����
��������
����������
��������
����������
������������� � ��� ������
������������������� ��
��������������������� ������� ������������ ������ �� !��
����������� ������ �� !��"���#���$%&��'���'(�)*�"���� �#�������� ��������+��,
Summary• The numbers of leukocyte subsets in the infected pigs markedly
decreased at d 3 to 7 PI, increased at d 14 to 28 PI and started
declining by d 35 PI.
• PRRSV increased the numbers of total leukocytes, neutrophils,
natural killer cells and several T cell subsets as compared to Sham.
• There were significant effects of day and day x PRRSV interaction on
subsets of leukocytes during the course of study.
• Dietary ACT increased the numbers of total leukocytes, B cells,
cytotoxic T cells and ���T cells as compared to the control.
• The diet x PRRSV interaction did not affect the numbers of total
leukocytes or any subsets of immune cells.
Conclusion• Feeding ACT to pigs results in increased peripheral blood
leukocytes, B cells, and T cells subsets which may be beneficial,
especially in bacterial co-infections.
• Changes in subpopulations of immune cells over the experimental
period would be a useful index of on-going processes of PRRSV
infection and for designing future treatment approaches.
Acknowledgments: The authors gratefully thank Alltech, Inc. for supporting this research.
ResultsFigures: Changes in peripheral blood immune cells in pigs fed CON or ACT
diet with or without PRRSV
IntroductionMannan-containing products have been shown to affect innate and adaptive
immunity in animals. Different products may have diverse immunomodulatory
effects.
Therefore, evaluation of effects of Actigen™ (ACT, a refined yeast-based
mannan preparation, Alltech, Inc.) on immune responses of pigs under disease-
challenged conditions is needed.
ObjectiveTo determine effects of ACT on serum levels of cytokines and haptoglobin
(Hp) in pigs experimentally infected with porcine reproductive and respiratory
syndrome virus (PRRSV)
Materials and Methods
Animals, experimental design, & feeding:
• Weaned pigs (n = 64, 32 gilts and 32 barrows), 21 d old, free of PRRSV
• RCBD, 2 x 2 factorial arrangement, blocks (initial BW within sex)
• Factors: diet (control & 0.04% ACT), PRRSV (with & without)
• 4-phase feeding program with declining diet complexity
Experimental procedures:
Measurement of serum inflammatory mediators:
• Tumor necrosis factor (TNF)-�, IL-1�, interferon (IFN)-�, IL-10, IL-12, Hp
• At d 0, 3, 7 postinoculation (PI) and weekly until d 42 PI
• 8 replicates per treatment, using commercial ELISA kits
Statistical analysis:
• Data were analyzed as repeated measures over time using the MIXED
procedure of SAS.
Actigen™ increases serum levels of cytokines and haptoglobin in pigs experimentally infected with PRRS VirusT. M. CHE*1, M. SONG1, R. W. JOHNSON1, K. W. KELLEY1, W. G. VAN ALSTINE2, K. A. DAWSON3, AND J. E. PETTIGREW1
1DEPARTMENT OF ANIMAL SCIENCES, UNIVERSITY OF ILLINOIS, URBANA, IL, 2ANIMAL DISEASE AND DIAGNOSTIC LABORATORY, PURDUE UNIVERSITY, WEST LAFAYETTE, IN, AND 3ALLTECH INC., NICHOLASVILLE, KY
�������
����� �� ����
��������
����������
��������
����������
������������� � ��� ������
������������������� ��
��������������������� ������� ������������ ������ �� !��
����������� ������ �� !��"���#���$%&��'���'(�)*�"���� �#�������� ��������+��,
8��
6
'�
�''�
�''�
�''�
8''�
�''�
���+ ����$$����/
'� �� 7� �8� ��� �9� ���
*;<�
-*)�
�*;<�
�-*)�6
66
6
6
6
6
6
)<0+�α&���1$%
������������������������������)#�������������������
"�/������ ������� ���
'�
�'�
8'�
�'�
9'�
�''�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
�%+��β&���1$%
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
6 6
6 6
�������������������������������������������������)#�������������������
'�
�'�
8'�
�'�
9'�
�''�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
)� ������+���) +��
�0<�+�
γ&���
1$%
���������������)#�������������������
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
6
66
6 6
'�
�''�
��''�
�9''�
�8''�
�'''�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
*;<�
-*)�
�*;<�
�-*)�6
6
6
6
66 6
66
��������������������������������������)#�������������������
�%+��&���1$%
'�
8'�
9'�
��'�
��'�
�''�
'� �� 7� �8� ��� �9� ��� 8��"�/������ ������� ���
*;<�
-*)�
�*;<�
�-*)�6
6 6 6
6
6
6
6
6
��������������������������������������)#�������������������
�%+�'&���1$%
'�
9''�
��''�
�8''�
��''�
8'''�
'� 7� �8� �9� 8��
?�&�@�1$%
*;<�
-*)�
�*;<�
�-*)�6
6
6
6 6
6
������������������������������������)#�������������������
"�/������ ������� ���
ResultsFig. Serum cytokine & Hp levels in pigs fed
CON or ACT diet with or without PRRSV
Summary• PRRSV increased the levels of
inflammatory mediators involved in
innate, Th-1, & T-regulatory responses.
• PRRSV induced secretion of innate and
Th-1 cytokines as early as d 3 PI, but
anti-inflammatory mediators at later time
points (d 7 or 14 PI).
• ACT enhanced IL-1�, but reduced TNF-�
in pigs.
• ACT increased IL-1�, IL-12, IL-10, & Hp in
infected pigs, but not in Sham. The IL-1� &
IL-12 favorably promote innate and T-cell
immune functions, whereas IL-10 is anti-
inflammatory and capable of stimulating B
cell-produced antibodies.
ConclusionThe modulation of secretion of
inflammatory mediators by Actigen™ at
critical time points may enhance protection
against PRRSV and secondary bacterial
infections.
Acknowledgments: The authors gratefully thank Alltech, Inc. for supporting this research.
IntroductionReviews of the literature have shown that Bio-Mos® positively influences
the growth rate and feed conversion efficiency of piglets immediately post
weaning (Miguel et al., 2004), as well as in the grow-finish period (Rosen,
2006). The purpose of this summary is to review all the available studies
when Bio-Mos® was included in the diet of the sow and to evaluate the
responses obtained.
Description of trialsIn total, 12 studies have been carried out (Table 1). Data were analysed
with Bio-Mos® inclusion as the main effect to determine its impact on sow
and pre-weaning piglet performance.
Effect on litter size and pre-weaning mortalityIncluding Bio-Mos® in the diet of the sow in late gestation did not influence
the number of piglets born alive (11.24 vs 11.14), but the number of piglets
weaned was numerically higher: 10.11 (±1.09) vs 9.67 (±0.74) (p>0.05) (Figure
1). When adjusted for differences in the numbers born alive, the increase in
litter size was 0.32 (±0.34). This increase resulted from a 21.0% decrease in
pre-weaning mortality, from 11.5 (±1.85) to 9.13 (±1.60) (p<0.05) (Figure 2).
Effects on birth weight and weaning weightThe inclusion of Bio-Mos® in the diet of the sow resulted in the mean
birth weight increasing from 1.46 (±0.11) to 1.52 (±0.11) kg; a difference that was significant
(p<0.05) in several of the studies.
Across all studies, weaning weight increased from 6.87 (±1.25) to 7.17kg (p>0.5); an increase of
0.30 kg (Figure 3). For several of the individual studies this difference was significant (p<0.05). When
differences in litters size were considered, mean litter weaning weight was increased by 6.0 (±2.75)
kg, representing a 9.0% increase over the controls.
Effects on colostrum quality and quantityIn 5 studies colostrum samples were taken within the first 24 h of farrowing and the concentration
of IgA, IgG and IgM analysed (Table 2).
In several studies there were increases (p<0.05) in individual Ig concentration. Across all studies
there was a 5.8, 8.1 and 15.1% increase in IgA, IgG and IgM, respectively, when Bio-Mos® was
included in the sow diet. In one study (Le Dividich et al. 2009) an
increase in growth rate of piglets within the first 24 h of age was
reported, which was associated with an increase in colostrum
production (Table 3).
Other effectsOther effects observed have been a reduction in the weaning-to-
oestrus period, a greater proportion of sows mated within 7 days
and a carry-over effect into the post-weaning period which resulted
in an improvement in the growth rate of piglets post weaning.
Overall ConclusionsThe results of this review show that when Bio-Mos® is included in the diet of the sow during
gestation and lactation, the following responses were recorded:
• An extra 0.32 piglets weaned per litter = 0.77 piglets/sow/year
• An improvement in piglet weaning weight of 0.30 kg
• An increase in the concentration of immunoglobulin in colostrum
• An increase in colostrum production during the first 24 h post partum
• Improved piglet growth rate in the first 24 h of life
• A ‘carry-over’ effect with higher performance of piglets post weaning
• Reduced wean-oestrus period = fewer empty days = more litters born
• A very cost-effective response with an ROI of 5.8:1
The responses to Bio-Mos®
in sow diets are therefore
consistent, with considerable
advantages for both sow and
piglet performance and hence
profitability. The recommended
level of inclusion of Bio-Mos® in
sow diets is 1 kg/ton throughout
gestation, lactation and post
weaning.
References available on request
The influence of the mannan oligosaccharide Bio-Mos® on sow and piglet performance: an overview
W. H. CLOSE, CLOSE CONSULTANCY, WOKINGHAM, BERKSHIRE, UK; J.A. TAYLOR-PICKARD, ALLTECH INC., DUNBOYNE, CO. MEATH, IRELAND; K.A. JACQUES, ALLTECH INC., NICHOLASVILLE, KY, USA
Table 1. Bio-Mos® in sow diets: Description of studies and measurements
Bio-Mos application Litter size Piglet weight
Study No Country
Nos of Sows Gestation Lactation
Total born
Born alive Weaned
Birth weight
Weaning weight
Colostrum quality
1 USA 24 5 g/d (14d) 5 g/d (21d) √ √ √
2 USA 1028 2 kg/t (21d) 1 kg/t (21d) √ √ √ √ √ √
3 USA 318 5 g/d (21d) 5 g/d (21 d) √ √ √ √ √ √
4 Croatia 221 2 kg/t (14d) 2 kg/t √ √ √ √
5 Italy 480 1.5 kg/t (60d) 1.5 kg/t √ √ √ √
6 Argentina 334 1.5 kg/5 (25d) 1.0 kg/t (16d) √ √ √
7 Spain 80 2 kg/t (14d) 1 kg/t (28d) √ √ √ √ √ √
8 Hungary 81 2 kg/t (42d) 1 kg/t (28d) √ √ √ √
9 France 52 4 g/d (84d) 4 g/d (21d) √ √ √ √ √ √
10 Canada 48 1 kg/t (throughout
gest.)
1 kg/t (21d) √ √ √ √ √ √
11 Mexico 270 1.5 kg/t (21d) 1.5 kg/t (21d) √ √ √ √
12 Poland 30 8 g/d (30d) 8 g/d (21d) √ √ √ √ √
Poland 30 8 g/d (30d) 8 g/d (21d) √ √ √ √ √
Table 2. The effect of Bio-Mos® on colostrum quality.
No. of sows IgA IgG IgM
Study No
Control Bio-Mos Units Control Bio-Mos Control Bio-Mos Control Bio-Mos
1 12 12 mg/dl 667 629 3565 4215* 326 440*
2 42 48 mg/dl 1097 1178 4842 5853* 241 273*
3 15 15 mg/dl 986 967 3252 3208 309 344
9/10 10 10 mg/dl 174 219* 1134 1095 150 149
12 (a) 15 15 mg/dl 11.77 11.91 79.26 87.33* 6.88 7.82*
12 (b) 10 20 mg/dl 12.21 13.17 84.94 91.63* 7.43 8.42*
* Denotes statistical significance (p<0.05)
Table 3. Effect of Bio-Mos® on colostrum production and piglet growth rate (Le Dividich et al., 2009).
France Canada
Control Bio-Mos Control Bio-Mos P
Piglet growth
(0-24 h), g
83 123 138 164 0.02
Colostrum
consumed/piglet, g
304 362 364 385 0.04
Colostrum (l/day) 3.36 3.92 4.28 4.84 0.02
Figure 1. Improvements in piglets weaned per litter in response to Bio-Mos®.
��������� ��� ������A������1�� ����
)� ���<�=
'� � � 8 � � 7 9 , �' �� �� >���
'=�
'=8
'=�
'=9
�
�=�
�=8
Figure 2. The effect of Bio-Mos® on pre-weaning mortality.
>����� �/��(
�
*������
)� ���<�=
'
�
8�
9
�'
��
�8
��
� � � 8 � � 7 9 , �' �� �� >���
3 �+>��
Figure 3. The effect of Bio-Mos® on the increase in piglet weaning weight.
��������� ��A��� ��
�A�=��:��
)� ���<�=
+'=�
'
'=�'=�
'=�
'=8
'=�
'=�
'=9
'=7
� � � 8 � � 7 9 , �' �� �� >���
����������Actigen™ is derived from Saccharomyces cerevisiae and
designed to help animals of all species thrive and reach
their genetic potential. In research trials conducted
in pigs, Actigen™ was shown to be as efficacious
as common antibiotic growth promoters (AGPs).
However, there is still a need to verify these results in
commercial settings and against different AGPs.
Objective
To compare the performance of post-wean pigs fed
Actigen™ versus that of those fed the common AGP
strategy, colistin + amoxicillin.
Materials and methods
Experimental design• 120 newly weaned, Large White-Landrace x Pietrain-
Duroc pigs (7.01+0.57 kg)
• Completely randomized experimental design
• 2 treatment groups
• 15 pigs/pen x 4 pens/trt
• Naturally ventilated, elevated-plastic slatted nursery
• 2 nipple drinkers/pen and a rotary automatic feeder
• Pigs exhibiting loose and watery diarrhea were
injected with 1 cc/d of colistin injectable until the
scours stopped.
• Management practices were the same between groups.
• Feed available ad libitum
• Feeding trial duration = 34 days
Treatments• Control – diet with 4 kg/ton colistin-
amoxicillin feed premix (amoxicillin 10%
+ colistin 10M IU/kg)
• Actigen™ – diet with 0.4 kg/ton
Actigen™ (Alltech, Inc.)
Measurements• Start and final weights, daily feed intake, and
mortality
• Scouring % was calculated as the total number of
pigs exhibiting loose and watery diarrhea within 1
to 7 d post-wean over the total number of pigs per
pen. Individual pigs were counted once only during
the trial.
Data analysis• ANOVA with MS Excel Statistical Analysis Package.
• Treatment effect on scouring and mortality was
analyzed using Chi-Square Goodness-of-Fit test.
Results• Final weight, ADG and feed intake did not differ
between treatments (P>0.05).
• FCR tended to be better in the Actigen™-fed pigs
compared with the colistin-amoxicillin-fed pigs (P=0.07)
• Mortality % and scouring % did not differ between
treatments (X2 = 2.67, 0.53, respectively)
• Medication cost (injectable) was the same for both
treatment groups.
• In-feed medication cost per pig was lower for
the Actigen™ group compared with the colistin-
amoxicillin group ($0.10 vs. $0.78, respectively).
Conclusions
Overall, performance of post-wean pigs (up to 64 d
of age) was similar between the Actigen™ or colistin-
amoxicillin treatments. Actigen™ was the more
economical option.
The effect of Actigen™ on post-wean pig performance compared with an antibiotic growth promoter�����%��&���#����%$&'����#���������������(��' �������)��*$� ������ '��$+1College of Veterinary Medicine, De La Salle–Araneta University, Malabon City, Philippines, 2Kalaw Farm, Brgy Santiago, Malvar Batangas, Philippines, 3Alltech Biotechnology Corp, Muntinlupa City,
Philippines, 4Alltech Biotechnology Ltd Pty., Melbourne, Australia
Table 1. Performance of pigs fed Actigen™ or colistin-amoxicillin treatments.
Colistin-amoxicillin Actigen™ SEM P-value
Initial weight, kg 7.01 7.01 0.203 0.99
Final weight, kg 20.33 20.40 0.581 0.96
ADG, g/d 392 394 0.015 0.96
Average daily feed intake, g/d 719 687 0.025 0.55
FCR 1.84 1.75 0.026 0.07
Mortality, % 0.00 3.3 NS
Scouring, % 23 23 NS
Medication cost (injectable)1, $/pig 0.03 0.03
Medication cost (in-feed)2, $/pig 0.78 0.10
1Colistin injectable, 1 cc/pig/d; calculated as the total cost per pen divided by 15 pigs/pen and averaged for
all replicates.2Medication cost (in-feed) per pig was calculated as the average of the actual cost of in-feed medication used
per replicate pen divided by the number of pigs per pen.
NS – Did not differ (P>0.05)
Introduction
In most countries cattle are fed diets with corn that is still
on the cob. In the Philippines, corn prices average PhP 10–13/
kg, whereas corn on the cob bought direct from the farm
costs 50% less. Devegowda et al. (2007) showed that there
are no deleterious effects in replacing corn with corn ear
when Allzyme® SSF (Alltech Inc.) is added to layer diets.
Objective• To determine the effect of partially replacing corn with
corn ear on the performance of finishing pigs from 50 kg
to slaughter.
• To determine the effect of Allzyme® SSF on diets containing
corn ear in finishing pigs.
Materials and methods
Experimental design• 336 mixed sex, LW-LR x PD pigs (49+0.95 kg)
• Complete randomized design
• 4 treatment groups
• 28 pigs/pen; 3 reps/trt
• Corn ear specs calculated using EvaPig program of actual
proximate analysis
• Feeding phases: Grower (56 d);
Finisher (21 d)
Treatments• Control – Corn-soy diet
• T1 – Control (reformulated to
replace corn) + 25% corn ear
• T2 – T1 + 200 g/ton Allzyme® SSF
• T3 – T1 + 400 g/ton Allzyme® SSF
Measurements• Body weight, feed intake, ADG,
FCR, feed costs.
Data analysis• ANOVA using Statistix v9.0
Results• Replacing corn with dried corn ear at 25% did not
adversely affect growing-finishing pig performance (Table 1,
Figures 1–4).
• The cost reduction by using corn ear was $20 per ton
(Table 1).
• Allzyme® SSF at 200 g/ton added to diets with 25% corn
ear improved (P<0.05) overall FCR by 15 pt (Table 1,
Figure 4).
• Allzyme® SSF at 200 g/ton added to diets with 25% corn
ear improved cost of gain by
– PhP 70 per pig ($1.50) over diets with 25% corn ear.
– PhP 194 per pig ($4.22) over corn-soya diets.
• Note: Freshly harvested corn ear must be dried to
desirable moisture content (preferably <14%) before
hammer milling. Proper drying is essential to prevent
mold growth.
Conclusions• Corn ear can replace 25% of corn in growing-finishing pig
diet without adversely affecting performance.
• Adding Allzyme® SSF to diet containing 25% corn ear can
further increase profit potential.
The effect of Allzyme® SSF on the performance of finisher pigs fed corn ear as partial replacement of corn���,&������%�����-���������!%���$'���������)��*$� �����!����)��$� 1Camille Farm, Gen. Santos City, Philippines, 2Alltech Biotechnology Corp., Muntinlupa City, Philippines, 3Alltech Biotechnology Pty Ltd.,
Bangkok, Thailand
Table 1. Effect of corn ear and Allzyme® SSF on pig performance and cost.
Parameter
Treatments
P value SEMControl
(corn-soya)Neg Control
(25% corn ear)Neg control + 200 g/t SSF
Neg con + 400 g/t SSF
Weight, kg
Initial 49.05 48.94 49.02 49.04 0.999 0.268
Grower 80.47 79.41 80.03 80.13 0.743 0.311
Final 95.98 94.86 95.36 95.01 0.878 1.047
Feed intake, kg/d
Initial 1.44 1.41 1.40 1.44 0.793 0.035
Grower 2.25 2.31 2.23 2.22 0.741 0.059
Final 1.66 1.66 1.63 1.65 0.938 0.040
Average daily gain, g/d
Initial 651 544 554 555 0.903 0.016
Grower 738 736 730 709 0.860 0.027
Final 609 596 602 597 0.947 0.017
FCR, g/g
Initial 2.57 2.59 2.53 2.60 0.327 0.025
Grower 3.33 3.14 3.06 3.15 0.827 0.208
Final 2.79a 2.79a 2.64b 2.72ab 0.040 0.034
Cost of gain, PhP/kg
Initial 38.01a 35.61bc 35.18c 36.70b 0.0015 0.337
Grower 45.12 40.06 39.52 41.56 0.527 2.815
Final 39.99a 37.23bc 35.67c 37.58b 0.002 0.498
Figure 1. Effect of corn ear and Allzyme® SSF on pig weight
��1��), +*�2�*�&')$�
���3�"�1*�,�4��5�"�*1��)*
6�1),
�
.
�
�����3����4�����+7�1��,,8#%����9���3����4����+7�1��,,8#%����9
��1*�,
2��+':�!+
Figure 2. Effect of corn ear and Allzyme® SSF on average daily gain
�
���
���
���
���
��
���
.��
+*�2�*
);�*)+
��<)
�,#�+)�1
6�1�$'�*
���3�"�1*�,�4��5�"�*1��)*
�;�*),,
��
���3����4�����+7�1��,,8#%����9���3����4����+7�1��,,8#%����9
��1*�,
Figure 3. Effect of corn ear and Allzyme® SSF on daily feed intake
�
��
�
��
�
+*�2�*
<)�,#�6�
�<��1)!�:�!+
6�1�$'�*
���3�"�1*�,�4��5�"�*1��)*
�;�*),,
��
���3����4�����+7�1��,,8#%����9���3����4����+7�1��,,8#%����9
��1*�,
Figure 4. Effect of corn ear and Allzyme® SSF on FCR
���
��
��.
���
���
���
+*�2�*
9��:�+
7+
6�1�$'�*
���3�"�1*�,�4��5�"�*1��)*
�;�*),,
��
���3����4�����+7�1��,,8#%����9���3����4����+7�1��,,8#%����9
��1*�,
Figure 5. Effect of corn ear and Allzyme® SSF on cost of gain
��
�
�.
��
��
��
�
+*�2�*
�'�
6�1�$'�*
���3�"�1*�,�4��5�"�*1��)*
�;�*),,
�.
���3����4�����+7�1��,,8#%����9���3����4����+7�1��,,8#%����9
��1*�,
IntroductionUnderstanding copper (Cu) absorption and
distribution mechanisms in weanling pigs is
important because it has been shown that Cu can
be fed as high as 250 ppm to provide an antibiotic-
like response that stimulates growth, even though
current requirements are set at only ~ 6 ppm.
Proper Cu homeostasis is necessary because free
Cu ions can become hazardous when superoxide
anions and hydrogen peroxide generate highly
toxic and reactive hydroxyl radicals. Variations in
dietary Cu level and/or source may affect serum
Cu concentrations or where and how Cu is taken
up by enterocytes, stored in the liver, excreted by
the gall bladder, or used in the kidney.
ObjectivesTo compare the effects of CuSO
4 and Bioplex®
(Alltech Inc.) when fed to weanling pigs on
intestinal, liver, gall bladder, kidney and serum Cu
concentrations.
Materials and methods• 70 crossbred barrows, weaned at 20±1 d of age
• 2x3 factorial design: Cu source (CuSO4 and
Bioplex® Cu) at 0, 4, 25, or 125 ppm
• 7 treatments;10 pigs/trt
• Diet (Table 1); treatments (Table 2)
• Sampling and analysis:
– Initial and final weights, feed intake
– Pigs were euthanized via asphyxiation with
CO2, 4 h after the first morning feeding.
– Immediately after death, proximal jejunum
(115 cm distal to pyloric sphincter), kidney,
liver and gall bladder samples were collected
and stored at -20 ºC.
– Before euthanasia, blood serum was isolated
and stored at -80 ºC till analysis.
– Cu concentrations were analyzed by ICP-
MS (inductively coupled plasma – mass
spectrometry).
• Data were analyzed in SAS:
– MIXED Procedure for 2x3 factorial design
– Linear or quadratic contrasts on Cu
concentrations.
Results• Two wks of Cu supplementation was insufficient
to substantially improve ADG (P=0.12) or G:F
(P=0.11, data not shown).
• After 2 wks, Cu at 125 ppm from either source
increased (P<0.05) Cu concentration in the
intestine (jejunum), liver, kidney, gall bladder
contents and serum (Figures 1 – 4).
• Cu source X Cu concentration interaction was
observed in serum (P<0.02):
– 11.4% increase in response to CuSO4
compared with Bioplex® Cu at 25 ppm Cu
– 11.8% increase in response to Bioplex® Cu
compared with CuSO4 at 125 ppm Cu
• Cu was higher (P<0.001) when fed at 125
ppm, with Cu from CuSO4 resulting in a 31.1%
increase (vs Bioplex® Cu) in Cu found in the
excretory route via gall bladder contents.
• Surprisingly, when Cu was fed at 125 ppm,
kidney stores of Cu almost doubled (P<0.05),
resulting in Cu stores similar to those of the
small intestine.
ConclusionTwo weeks of supplementation using either
Bioplex® Cu or CuSO4 at 125 ppm greatly
increased Cu stores in intestine (jejunum),
liver, kidney, and gall bladder. At this same dose,
Bioplex® Cu provided an 11.8% advantage over
CuSO4 in increasing serum Cu concentration.
Intestinal, liver, kidney, serum and biliary Cu concentrations in piglets fed Cu proteinate or CuSO4
%���$����!$�!����� ����# ��$�����$������ �����!��' �����!'��..�
1Purdue University, Animal Sciences Department, West Lafayette, IN , 2Center for Animal Nutrigenomics and Applied Animal Nutrition, Alltech Inc., Nicholasville, KY
Table 1. Composition of negative control, basal diet.
Ingredients % of diet
Ground corn 52.551
Whey 5.630
Soybean meal, 47.5% CP 5.641
Lactose 18.072
Spray dried plasma 5.000
Casein, dried 7.409
Soybean oil 4.011
Limestone 0.283
Monocal phosphate 0.242
Lysine HCL 0.134
DL-Methionine 0.070
L-Threonine 0.032
L-Tryptophan 0.050
Se 600 0.050
Cellulose 0.125
Salt 0.350
Vitamin premix1 0.250
Trace mineral premix2 0.125
Calculated composition of diet3
ME, kcal/kg 3334
CP, % 16.76
Lys, % 1.35
Met, % 0.442
Met + Cys, % 0.760
Trp, % 0.240
Thr, % 0.860
Ca, % 0.80
available P% 0.40
1Per kg of diet: 2,640,000 IU Vit. A, 264,000 IU Vit. D3,
17,600 IU Vit. E, 880 mg menadione, 14.5 mg Vit. B12
,
13,200 mg niacin, 8,800 mg pantothenic acid, 3,520
mg riboflavin. 2 Per kg of diet: 15 g Mn, 338.0 g Zn, 387.1 g Fe, and
1.9 g I.3 Calculated trace mineral content of basal diet, not
provided by the trace mineral premix, is 3.73 mg/kg Cu,
15.34 mg/kg Zn, 6.17 mg/kg Mn and 36.27 mg/kg Fe.
Table 2. Expected and actual Cu concentrations for each dietary treatment.
Supplemental Cu
Treatment
Control CuSO4 Bioplex Cu
0 ppm 4 ppm 25 ppm 125 ppm 4 ppm 25 ppm 125 ppm
Calculated, ppm 3.7 7.7 28.7 128.7 7.7 28.7 128.7
Actual, ppm 3.4 6.7 32.5 145.0 8.0 38.0 146.7
Figure 1. Effect of 2 weeks of Bioplex® Cu or CuSO4 supplementation on intestinal (jejunal) Cu concentrations (dry basis) in young pigs. Values are least square means.
�
��
��
��
��
�
��
.�
�
��
���
� � � ��
������ ����*�&���$
�
-�����*�&���$��
� �&&%��66�"3���������
��1�)*�� ��66�"3���������
Figure 3. Effects of 2 weeks of Bioplex® Cu or CuSO4 supplementation on kidney Cu concentrations (dry basis). Values are least square means.
�
��
��
��
�
���
� � � ��
B ���/�*�&���$
�
-�����*�&���$��
� �&&%��66�"3���������
��1�)*�� ��66�"3���������
Figure 2. Effects of 2 weeks of Bioplex® Cu or CuSO4 supplementation on liver Cu concentrations (dry basis) in young pigs. Values are least square means.
�
�
���
��
���
��
���
� � � ��
% ���*
�&���$
�
-�����*�&���$��
� �&&%��66�"3���������
��1�)*�� ��66�"3���������
Figure 4. Effects of 2 weeks of Bioplex® Cu or CuSO4 supplementation on gall bladder Cu concentration in young pigs. Values are least square means.
�
�
�
�
�
�
.
� � �� ��
.����3
�������*��������*�&���$
�
-�����*�&���$��
� �&&%��66�"3�����������1�)*�� ��66�"3���������
Figure 5. Effect of supplementing 0, 4, 25 or 125 ppm Cu from either Bioplex Cu or CuSO4 for 2 weeks on serum Cu concentrations in young pigs. Values reported represent least square means.
���
��
���
��
���
� � � ��
=&� � ���
����$�*�&���$
�
-�����*�&���$��
� �&&%-� ��� *"�3��������
��1�)*��66�"�6�*�� ���3���������
IntroductionPostweaning pigs fed unfortified corn-soybean meal diets can
develop a parakeratosis-like skin condition even when calcium
and phosphorus levels are otherwise adequate. Pigs have been
shown to recover from the skin condition after being fed
diet containing added trace minerals, which suggests that zinc
might be the primary limiting factor in complex corn-soybean
meal diets.
ObjectiveTo re-evaluate the zinc requirement in typical pig nursery diets.
MethodsExperimental design• 450 weanling pigs (weaned at 17 d, average wgt = 6.3 kg)
• 9 treatment groups, 10 reps (pens)/trt
• Phased feeding (Table 1): 1 – 10 d; 10 – 35 d
• Treatments
– Control with no added Zn
– Control + BioPlex® (Alltech Inc.) at 25, 50, 75, or 100 ppm
– Control + ZnSO4 at 25, 50, 75, or 100 ppm
– Note: Chalk (CaCO3) and Na
2HPO
4 were used to
provide Ca & P thus avoiding contaminating minerals;
phytase was included in all diets
• Duration of trial – 35 d
Measurements
– Body weight (BW) and feed intake at 0, 10, and 35 d
– 1 pig/pen killed d 10 & d 35 postweaning
– Liver, heart, kidney sampled; organ weight (g, % BW) and
Zn (total & ppm) determined.
Results• Supplemental Zn increased
growth performance:
– Pig BW at 35 d
postweaning
– ADG for the 0 to 10, 10
to 35, & 0 to 35 d periods
– G:F for the 0 to 10 d period
• ADG increased with
increasing levels of Bioplex®
Zn.
– ADG peaked at 75 ppm
for the 0 to 10 and 0 to
35 d periods.
– ADG peaked at 50 ppm
for the 10 to 35 d period.
• G:F increased with increasing
level of both Bioplex® and
inorganic Zn.
• Zn treatment did not
affect ADFI.
• Zn source did not
significantly affect
growth performance.
• Liver Zn:
– Zn concentration
increased with increasing
dietary Zn level at 10 d.
– Supplemental Zn
increased total Zn
content at 10 d.
– Liver wt. (g & %BW) increased quadratically with dietary
Zn level at 35 d.
– Zn concentration and content increased linearly with
dietary Zn at 35 d.
• Zn content of heart and kidney increased with dietary Zn
at 35 d.
• Zn source did not affect tissue mineral composition.
Conclusion• Conventional nursery diets need to be fortified with Zn.
• An additional 75 ppm Zn is adequate to meet pig needs for
growth.
• Innate Zn + added Zn ≈ 100 total ppm Zn needed to
maximize ADG
Effect of zinc level and source on postweaning pig performance and mineral status������ ���..�������������������/��������!����"��)��0�
1The Ohio State University, Columbus, 2Michigan State University, East Lansing
Table 1. Composition of phased diets.1
IngredientPhase 1 0 – 10 d
Phase 2 10 – 35 d
Corn 30.25 35.70
Soybean meal, 48% 15.00 17.50
Soy protein
concentrate
11.00 15.00
Lactose 20.00 18.00
Dried whey 15.00 10.00
Plasma protein 3.00 -
1Innate Zn: Phase 1 = 32 ppm; Phase 2 = 50 ppm
Table 2. Postweaning pig growth response to supplemental Zn sources and concentrations.1,2
Parameter
Treatment
Con 0 Org 25 Org 50 Org 75
Org 100
Inorg 25
Inorg 50
Inorg 75
Inorg 100
BW, kg
0 d 6.3 6.3 6.3 6.3 6.2 6.3 6.3 6.3 6.3
10 d 7.2 7.4 7.2 7.7 7.3 7.4 7.4 7.4 7.6
35 d 1 16.9 19.3 19.6 19.8 19.5 19.8 19.1 19.2 19.5
ADG, g/d
0 d 1,2 88 107 109 141 105 109 116 111 120
10 d 1,2 487 516 528 522 488 535 500 507 515
35 d 1,2 345 370 378 386 351 383 363 366 374
1Control vs supplemented trts P=0.05; 2Quadratic relationship with supplemental Bioplex Zn concentration, P<0.05
Table 3. Postweaning pig feed efficiency response to supplemental Zn sources and concentrations.1
Parameter
Treatment
Con 0 Org 25 Org 50 Org 75Org 100
Inorg 25
Inorg 50
Inorg 75
Inorg 100
ADFI, g/d
0 d 200 195 187 222 192 184 197 200 200
10 d 719 735 755 777 734 791 727 747 766
35 d 534 542 552 578 540 574 537 552 563
G:F, g:kg
0 d 2,3 200 195 187 222 192 184 197 200 200
10 d 679 702 699 672 665 676 688 679 672
35 d 576 699 684 667 678 674 674 698 662
1Control vs supplemented trts P=0.05; 2Linear relationship with supplemental Inorganic Zn concentration, P<0.053Quadratic relationship with supplemental Bioplex® Zn concentration, P<0.05
Table 4. Effect of supplemental Zn concentration on Zn content of liver.1
Parameter
Treatment
0 25 50 75 100
10 d
Weight, g 129 162 142 156 154
% BW 1.78 2.06 1.86 2.12 2.02
Zn2, ppm 46 57 56 57 47
Total Zn1, g 5.9 9.2 8.0 9.0 7.2
35 d
Weight2, g 651 743 741 748 749
% BW2 3.43 3.73 3.61 3.60 3.73
Zn3, ppm 30 31 46 59 77
Total Zn3, g 20 23 37 44 58
1Control vs supplemented P<0.052Quadratic relationship with supplemental Zn concentration, P<0.05 3Linear relationship with supplemental Zn concentration, P<0.05
Table 4. Effect of supplemental Zn concentration on Zn content of heart and kidneys at 35 d.
Parameter
Treatment
0 25 50 75 100
Heart
Weight, g 98 107 106 106 112
% BW 0.52 0.54 0.52 0.51 0.56
Zn, ppm 14 15 15 16 15
Total Zn1, g 1.4 1.6 1.6 1.6 1.7
Kidney
Weight, g 62 72 66 72 71
% BW 0.33 0.36 0.32 0.35 0.35
Zn, ppm 20 17 19 21 21
Total Zn1, g 1.2 1.3 1.3 1.5 1.5
1 Quadratic relationship with supplemental Zn concentration, P<0.05
ObjectiveTo determine the effect of feeding inorganic minerals to
grower-finisher pigs that had consumed only organic minerals
since birth.
Experimental design• 108 Large White-Landrace x Pietrain-Duroc, mixed-sex
(50:50) pigs
• Two treatment groups with 3 pens/trt, 18 pigs/pen
• Naturally ventilated barns, 1 m3/pig, 2 nipple drinkers/pen
• Feeding ad libitum, automatic feeders, 3 pigs per feeder hole
• Feeding program specs
– Grower feed from 40-70 kg BW, finisher feed 70 kg up
– Grower: 3,100 kcal ME, 1% total lysine, 0.85% Ca, 0.40%
available P
– Finisher: 3,000 kcal ME, 1% total lysine, 0.8% Ca, 0.35%
available P
• Treatments (see Table 1)
• Trial duration: 40 to 100 kg (84 to 142 d of age)
Results• Pigs that continued to be fed Sel-Plex® and Bioplexes® in
the grower-finisher phase were on average 3 kg heavier
compared with pigs that were switched to inorganic
mineral supplements (Table 2).
• Likewise, the average daily gain of pigs that continued to be
fed Sel-Plex® and Bioplex® in the grower-finisher phase was
10 g/d more, feed intake was 157 g/d more, and FCR was
13 point lower compared with pigs that were switched to
inorganic mineral supplements.
ConclusionIn pigs that had been fed Bioplexes® and Sel-Plex® (Alltech
Inc.) since birth, replacement of organic minerals with
inorganic mineral supplements in
the growing-finishing stage resulted
in reduced performance compared
with continued feeding with the
organic minerals.
Switching from Sel-Plex® and Bioplex® mineral supplements to inorganic minerals in the grower-
finisher phase was detrimental to pig performance��%��� ������!�����)��*$� �
1Tiaong Lucky Farm, Quezon, Philippines, 2Alltech Biotechnology Corp., Philippines
Table 1. Mineral composition of treatments.
Mineral Inorganic premix* Bioplex® + Sel-Plex®
Zn, ppm 75 60
Cu, ppm 8 10
Fe, ppm 100 60
Mn, ppm 30 15
Se, ppm 0.15 0.3
I, ppm 1.2 1.2
Cr, ppm 200 200
* Inorganic premix group was fed Bioplexes® + Sel-Plex® since birth
with no inorganic minerals.
Table 2. Effect of organic minerals on pig performance.
ParameterInorganic premix
Bioplex® + Sel-Plex® SEM P Difference
Initial weight, kg 41.22 41.10 0.49 0.911
Final weight, kg 93.81 96.93 1.01 0.127 + 3
ADG, kg/d 0.852 0.948 0.02 0.0048 + 10
ADFI, kg/d 2.49 2.65 0.06 0.0348 + 157
FCR 2.93 2.80 0.04 0.481 - 13
Methods• 68 sows
• Completely randomized experimental design
• 2 treatments (T1 & T2), with 35 & 33 replicates, respectively
• Treatments: T1 – Control; T2 – Control + 2.0% NuPro®
• Isonutritive diets formulated as per Rostagno et al. (2005)
• Controlled feeding: 3.0 kg of feed/d fed to sows from 95 to 110 d of age
• 5 d before farrowing, sows were individually penned and fed lactation feed (3.0 kg/d) until 12 h
before farrowing.
• After farrowing, sows were fed lactation feed divided into 2, 3 or 4 meals, until weaning (Table 1).
• Measurements included number of piglets born alive, stillbirths, mummified, return-to-estrus
rate, body score of sows at weaning. Piglets were weighed at birth, 7 d of age, and at weaning.
Occurrence of diarrhea, mortality rate and culling were recorded.
• Data were analyzed using ANOVA. Performance means were compared by F test; means for
mortality and incidence of diarrhea were compared by non-parametric test (P<0.05).
Results • No effects of treatments were observed on the reproductive parameters (P>0.05).
• At weaning, the sows from both treatments showed body score of 2.0. However, the weaning-
estrus intervals were 7.7 d (Control) and 7.0 d (NuPro®).
• Pre-weaning mortality rate and number of non-viable animals were lower in piglets born from
sows fed NuPro® during the pre-lactation and lactation phases (Table 2).
• NuPro fed to sows improved (P<0.05) piglet weight at birth, at 7 d of age and at weaning:
(+9.7, 11.75 and 12.34%, respectively). Likewise, average daily gain in piglets born from sows
fed NuPro® was 15 and 13% higher in the first week of life and from birth to 20 d of age,
respectively (Table 2).
Conclusions• Inclusion of NuPro® at 2% in sow diets during pre-lactation and lactation promoted better
performance of litter before weaning, including higher weight gain (+590 g/piglet), reduced
mortality, and reduced culling (- 4.8 percentage points).
• NuPro® inclusion showed positive ROI (2.66:1).
Use of NuPro® in pre-lactation and lactation sows: Effects on reproductive
parameters and litter performance#&1�����������/���������2�
1Allnutri Ltda., Viçosa, Minas Gerais, Brazil, 2 Alltech Brazil
Table 1 – Feeding of lactation diets according to the days of lactation
Days of lactation 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Kg of feed/day 2 3 3 4 4 5 5 6 6 6 6 6 6 6 6 6 8 8 8 8
Table 2 – Relative number and percentage of mortality and culling causes
Control total of 351 piglets born alive
Control + NuPro® – total of 337 piglets born alive
Causes 1st week After 1st week Causes 1st week After 1st week
Non-viable 19 (5.4%) Non-viable 5 (1.5%)
Culled 2 (0.5%) 2 (0.5%) Culled 2 (0.6%) 5 (1.5%)
Crushed 13 (3.7%) 3 (0.8%) Crushed 1 (0.3%) 8 (2.4%)
Total - 39 (11%) 34 (9.7%) 5 (1.4%) Total – 21 (6.2%) 8 (2.4%) 13 (3.8%)
Table 3 – Effect of NuPro® during the pre-lactation and lactation phases on live weight (LW), weight gain (WG) and average daily gain (ADG) of piglets.
LW (g)
WG (g)
ADG (g/d)
WG (g)
DWG (g/d)
Treatment Day 1 Day 7 Day 20 Days 1–7 Days 1–2
Control 1453B 2432B 4780B 978B 140B 3327B 167B
Control + NuPro® 1595A 2718A 5370A 1123A 160A 3774A 189A
CV 21.86 20.94 23.59 36.51 36.51 30.915 30.79
A,BMeans differ (P<0.05)
IntroductionNuPro® (Alltech Inc.) is a source of protein, amino acids, nucleotides and other essential
nutrients for swine. Several studies demonstrate that NuPro® improves weight gain, feed
consumption and immunological parameters of piglets. However, scientific results in
sows are still limited.
ObjectiveTo evaluate the effects of NuPro® on the reproductive performance of sows and the
subsequent development of their litters.
IntroductionCopper (Cu) is required by all living organisms for growth and
development and its unique characteristics (ox/redox) provide
for essential cofactors, helping physiologic functions such as
connective tissue formation, iron metabolism, melanin pigment
formation, cardiac function, cholesterol metabolism and immune
function. Though suitable for catalytic activity, the redox activity
of Cu renders it toxic when it accumulates at high levels through
the production of reactive oxygen species, and therefore can
alter cellular stress and activities. Little work has been done
to examine how dietary Cu affects gene transcription in the
enterocyte (intestinal absorptive cell) of the pig.
ObjectiveTo determine the effect of Bioplex® Cu (Alltech Inc.) or
CuSO4 on commonly regulated gene transcription in the
proximal jejunum.
Materials and methods• 30 crossbred barrows weaned at 20±1 d
• 3 treatment groups (n=10): Cu supplementation for 14 d at
0 ppm (control), 25 ppm (Bioplex®), or 25 ppm CuSO4
• Prior to receiving test diets all pigs were given 3 d of
commercial starter pellet, 4 days of basal diet (ad lib), then 3
days of 2 daily feedings at 9% MBW.
• Pigs were euthanized and proximal jejunual mucosal
scrapings collected and flash frozen.
• RNA was isolated from mucosal scrapings and components
from the GeneChip® 3’ IT express kit were used to reverse-
transcribe RNA to first-strand cDNA, as well as second-
strand cDNA synthesis. The GeneChip Porcine Genome
Array was used to test the expression of 23,937 gene
transcripts (as probe sets).
• GeneSpring GX 10.0 was used to quantify and normalize
microarray data and to perform statistical analyses.
– Raw signal intensities from the microarray data (.cel
files) were imported into GeneSpring and summarized
based on the MAS5 algorithm. Samples were baseline
transformed to the median of control samples.
• Filtered gene lists were subjected to statistical analysis
(t-test, P<0.05, Fold change (FC)>1.2) to identify
differentially expressed transcripts.
• Transcripts which differed (P<0.05 and FC>1.2) between
Bioplex® Cu, CuSO4 or control fed pigs were used for Core
Analysis (Ingenuity Pathway Analysis software).
• Transcripts were converted from NetAffx pig annotation to
human annotation database for 3’IVT Expression.
Results• Of the 24,123 possible transcripts, 71 genes were up/down-
regulated by both CuSO4 (out of 554) and Bioplex® Cu (out
of 396) (Figure 1); these indicate Cu-specific cellular functions.
• Network pathways of these Cu-specific genes are involved
in hematologic system development, immune cell trafficking
and inflammatory response, and include genes such as
modulator of frizzled homolog 4 (FZD4), protein tyrosine
phosphatase, protein phosphatase 2 (PPP2R1B), aptoptosis
1 (MOAP1), mitogen-activated protein kinase 3 (MAPK3),
chemokine receptor 7 (CXCR7), chemokine ligand 2
(CXCL2) and cytochrome c (CYCS).
• Other biologic networks altered by dietary Cu include
cellular assembly and organizational pathways, neurologic
and inflammatory disease; cell death, growth and
proliferation (Table 1).
– Links to fatty acid metabolic related genes include
peroxisomal trans-2-enoyl-CoA reductase (PECR) and
the fatty acid transporter SLC27A6.
– Potential alterations to gut permeability are suggested
by altered channel proteins: K+ large conductance Ca-
activated channel (KCNMB1) and gap junction protein
(GJA1).
• Of the 71 commonly expressed transcripts, 29 were
commonly up-regulated (Table 2) and 42 were commonly
down-regulated (Table 3) (P<0.05, FC>1.2).
– Upregulated networks included cellular morphology,
assembly and organization, lipid metabolism, molecular
transport and carbohydrate metabolism.
– Down-regulated networks included nervous system
development and function, gene expression, amino acid
metabolism, and post-translational modifications.
ConclusionThese data show novel, commonly regulated pathways
between CuSO4 and Bioplex® Cu, point to Cu-specific genes,
and transcriptionally verify Cu-related functions involved in
apoptosis, cell signaling and cellular immune responses in swine.
Microarray analysis of genes regulated by both Bioplex® Cu and CuSO4 in the jejunum of weanling pigs %���$����!$�!������3���4�� �����$$�������� ������� ����# ��$�����$������ ������!��' �����!'��..�
1Purdue University Animal Sciences Department, West Lafayette, IN, 2Center for Animal Nutrigenomics and Applied Animal Nutrition, Alltech, Nicholasville, KY
Table 1. Top networks and biofunctions common to CuSO4 and Bioplex®Cu in the proximal jejunum of weanling pigs.
Associated network functions Score
Hematological System Development and Function,
Immune Cell Trafficking, Inflammatory Response
47
Cellular Assembly and Organization, Cellular
Movement, Skeletal and Muscular Disorders
28
Cancer, Infectious Disease, Inflammatory Disease 26
Neurological Disease, Cardiovascular System
Development and Function, Organismal Development
20
Cell Death, Cardiac Necrosis/Cell Death, Cellular
Growth and Proliferation
14
Top Biological Functions No. altered Genes
Molecular and Cellular Functions
Cell Cycle 11
Cell Death 21
Cellular Compromise 5
Energy Production 4
Nucleic Acid Metabolism 5
Diseases and Disorders
Cancer 30
Gastrointestinal Disease 14
Inflammatory Response 6
Dermatological Diseases and Conditions 8
Developmental Disorder 10
Physiological System Development and Function
Hematological System Development and Function 9
Immune Cell Trafficking 6
Tissue Development 9
Cardiovascular System Development and Function 7
Connective Tissue Development and Function 5
Table 2. Top networks and biofunctions up-regulated by both Bioplex®Cu and CuSO4 in the proximal jejunum of weanling pigs.
Associated up regulated network functions Score
Cell Morphology, Cellular Assembly and Organization,
Cardiac Proliferation
32
Drug Metabolism, Endocrine System Development and
Function, Lipid Metabolism
31
Cellular Assembly and Organization, Hair and Skin
Development and Function, Organ Morphology
27
Lipid Metabolism, Molecular Transport, Small Molecule
Biochemistry
24
Carbohydrate Metabolism, Lipid Metabolism, Small
Molecule Biochemistry
22
Top Biological Functions No. altered Genes
Molecular and Cellular Functions
Post-Translational Modification 12
RNA Damage and Repair 3
Cell-To-Cell Signaling and Interaction 8
Cellular Assembly and Organization 18
DNA Replication, Recombination and Repair 12
Diseases and Disorders
Immunological Disease 3
Inflammatory Disease 4
Gastrointestinal Disease 4
Organismal Injury and Abnormalities 10
Physiological System Development and Function
Cardiovascular System Development and Function 14
Organ Development 14
Connective Tissue Development and Function 12
Skeletal and Muscular System Development and
Function
8
Tissue Morphology 10
Table 3. Top networks and biofunctions down-regulated by both Bioplex® Cu and CuSO4 in the proximal jejunum of weanling pigs.
Associated down regulated network functions Score
Gene Expression, Organ Development, Cell-To-Cell
Signaling and Interaction
45
Nervous System Development and Function, Cell
Morphology, Cellular Development
34
Gene Expression, Cell Morphology, Cellular Assembly
and Organization
25
Tumor Morphology, Amino Acid Metabolism, Post-
Translational Modification
25
Lipid Metabolism, Molecular Transport, Small Molecule
Biochemistry
25
Top Biological Functions No. altered Genes
Molecular and Cellular Functions
Cellular Compromise 12
Cellular Assembly and Organization 23
Cellular Development 15
Gene Expression 24
DNA Replication, Recombination and Repair 10
Diseases and Disorders
Gastrointestinal Disease 34
Genetic Disorder 114
Inflammatory Disease 54
Cardiovascular Disease 53
Endocrine System Disorders 53
Physiological System Development and Function
Embryonic Development 14
Tissue Development 16
Organismal Development 25
Nervous system Development and Function 20
Hematological System Development and Function 10
Figure 1. Venn diagram of transcripts commonly expressed in the proximal jejunum of weanling pigs when fed 25 ppm Cu from either CuSO4 or Bioplex® Cu. Of the 71 commonly expressed genes, 42 were down-regulated and 29 up-regulated.
878*��;8
�4�������������� ���
7�*�$$���/�4�������������� ���
���*������� �����4�������������� ���
IntroductionThe term ionomics refers to the mineral nutrient
and trace element composition of a biologic
system. From the ionomic profile of organs in the
pig, we can understand how changes of one dietary
mineral concentration and form can alter the
status of other minerals. Antagonist or protagonist
mineral relationships can occur for a variety of
reasons including precipitation, competition for
shared transport, similar chemical structure, and
shared transcription factors that can up or down
regulate gene transcription. Although we know
certain mineral-mineral interactions exist, it is not
clear which dietary concentrations and forms of
Cu interact and alter the status of other minerals
in select organs.
ObjectiveTo compare the effects of CuSO
4 and Bioplex®
Cu (Alltech Inc.) on the ionomic profiles
(intestinal, liver, gall bladder contents, kidney, and
serum) of weanling pigs.
Materials and methods• 70 crossbred barrows, weaned at 20±1 d of age
• 2x3 factorial design: Cu source (CuSO4
and Bioplex® Cu) at 0, 4, 25, or 125 ppm in
complex diet
• 7 treatments;10 pigs/trt
• Diet (Table 1); treatments (Table 2)
• Sampling and analysis:
– Pigs were euthanized via asphyxiation with
CO2, ~4 h after the 1st morning feeding.
– Immediately after death, proximal jejunum
(115 cm distal to pyloric sphincter),
kidney, liver and gall bladder samples were
collected and stored at -20 °C.
– Before euthanasia, blood serum was
isolated and stored at -80 °C till analysis.
– Mineral concentrations were analyzed by
ICP-MS.
• Data were analyzed in SAS:
– MIXED Procedure to analyze 2x3
factorial design
– GLM Procedure to run linear or quadratic
contrasts on mineral concentrations.
Results• Figure 1 shows changes in organ Cu
concentrations in response to changes in
dietary CuSO4 or Bioplex® Cu.
Antagonist mineral-mineral relationships• As dietary Cu increased, intestinal
molybdenum (Mo) and magnesium (Mg)
(Figure 2) concentrations decreased linearly.
• Intestinal and kidney Zn concentrations
(Figure 3) decreased significantly only when
Cu was fed at 25 ppm.
• The addition of 125 ppm dietary Cu, decreased
the concentrations of Mo and selenium (Se)
(Figure 4) in gall bladder contents.
Protagonist mineral-mineral relationships• Zinc concentration in gall bladder contents
increased only with the lowest level of dietary
Cu (4 ppm) (Figure 5).
• Liver concentrations of manganese (Mn) and
Se (Figure 6) increased linearly as dietary Cu
increased.
• Feeding 125 ppm Cu significantly increased
concentrations of cobalt (Co) and Mn in the
kidney, Co in serum (Figure 7), and iron (Fe) in
the intestine.
Heavy metal accumulation• Feeding increasing levels of Cu linearly
increased liver lead (Pb) (Figure 8) and Cd–
with more of each accumulating from CuSO4
compared with Bioplex® Cu.
• Level of Cd accumulation in the kidney was
highest at 125 ppm Cu; the increase was 16%
greater for pigs fed CuSO4 (Figure 9).
Serum selenium and Mo
• Overall, when pigs were fed Cu from Bioplex® Cu, more serum Se (Figure 10) and Mo was
present in blood serum.
Implications• Mineral-mineral antagonist and protagonist
relationships should not be generalized,
but rather defined based on mineral
concentrations/forms and target organs.
• Dietary Cu affects the metabolism of a variety of
minerals, which is an important consideration in
establishing dietary requirements.
• These data show that heavy metal
accumulation occurs when Cu is fed at higher
levels; this accumulation is less pronounced
for Bioplex® Cu than for CuSO4.
Ionomic profile changes in the intestine, liver, kidney, serum and gall bladder contents due to copper source and concentration %���$����!$�!����� ����# ��$�����$������ �����!��' �����!'��..�
1Purdue University, Animal Sciences Department, West Lafayette, IN, 2Center for Animal Nutrigenomics and Applied Animal Nutrition, Alltech Inc., Nicholasville, KY
Figure 1. Effects of 2 weeks of Bioplex® Cu or CuSO4 supplementation on intestinal (jejunal), liver, kidney, gall bladder contents, and serum Cu concentrations in young pigs.
'' 8
-�����*�&���$
*����$�������#��C'=''�% �����*����������C'=''�
�� ���
% ���*
�&���$
�''
��'
�''
��'
�''
�'
-�����*�&���$
'' 8
*����$�������#��C'=''�% �����*����������C'=''
�� ���
�'
�'
�'
8'
�'
������ ����*�&���$
�'
7'
9'
,'
�''
'' 8
-�����*�&���$
*����$�������#��C'=''�% �����*����������C'=''�
�� ���
B ���/�*�&���$
�''
9'
�'
8'
�'
'' 8
-�����*�&���$
*����$�������#��C'=''�% �����*����������C'=''�
�� ���
.����3
�������*��������*�&���$
7
�
�
8
�
�
�
'='' 8
-�����*�&���$
*����$�D*��������#��E'='�% ����������������*��;8#��C'=''�
�� ���
����$�*�&���$
�='
�=�
�='
'=�
3 ����4�*�
*��;8
Figure 2. Inverse linear relationship between dietary Cu and intestinal Mg concentrations.
-�����*�&���$
,�'' 8
*����$�������#��C'=''�% �����*����������C'=''�
�� ���
������ ����>�&���$
���'
��''
���'
��''
�'�'
�'''
Figure 7. Feeding 125 ppm Cu significantly increased concentrations of Co in serum.
'=''
'='�
'=�'
'=��
'=�'
'=��
'=�'
'=��*����$�������#��C'=''�% �����*��������#�C'=''�
' 8 �� ���-�����*�&���$
����$�*�&���2
Figure 8. Increasing levels of dietary Cu were associated with increased levels of Pb in liver; Pb in liver was higher with CuSO4.
'
�
�'
��
�'
��
�'
��
8'�������
� ���
*����$�������#��E'='�% ����������������*��;�#��E'='�
' 8-�����*�&���$
�� ���
% ���%
���&���$
Figure 9. Cadmium accumulation was greatest at 125 ppm dietary Cu; accumulation was 16% greater from CuSO4.
'
�'
�'
�'
8'
�'
�'
7'
9'
�������
� ���
*����$�������#��E'='''�% ����������������*�#��C'=''�
' 8-�����*�&���$
�� ���
B ���/����$
�$&���2
*����$D*���������������#��E'=��
Figure 10. Overall serum Se level was higher in response to Bioplex® Cu compared with CuSO4.
'
�'
8'
�'
9'
�''
��'
�8'
��'
�9'*���������)����#��E'=��
-�����*�&���$
����$���&���2
������� � ���
Figure 3. Reduction in kidney Zn concentration for dietary Cu dose of 25 ppm.
���
��'
���
��'
���
�8'
�8�
��'
���
' 8 �� ���-�����*�&���$
*����$�������#��E'='�F������ ��*�������#��E'='9
B ���/�G�
&���$
Figure 4. Copper at 125 ppm reduced Se concentration in gall bladder contents.
'�'�'�'8'�'�'7'9','�''
' 8 �� ���-�����*�&���$
*����$�������#��E'='�% �����*��������#��E'='8
.3*���&���$
Figure 5. Zinc concentration in the gall bladder contents increased at the lowest level of dietary Cu only.
'
�''
�''
�''
8''
�''
�''*����$�������#��E'='�F������ ��*��������#��E'='�
' 8 �� ���-�����*�&���$
.3*�G�&���2
Figure 6. Liver Se increased linearly with dietary Cu concentration.
'
'=�'
�=''
�=�'
�=''
�=�'
�=''
' 8 �� ���-�����*�&���$
% ����
�&���$
*����$�������#��E'=''�% �����*��������#��E'=''�
Use of Actigen™ – Performance, E. coli control and antimicrobial revitalizationDRA. GERTRUDES CORÇÃO¹, ALESSANDRA ALVES DE PAULO², MELISSA ISABEL HANNAS², ANDERSON A. DA VEIGA²; ¹ UFRGS, ALTECH DO BRAZIL²
Proposal
The aim of the study was to control secondary bacterial growth in swine during growing
and finisher phases, through the synergistic effect among the use of antibiotic and ActigenTM,
minimizing the effects of the secondary diseases which can be increased by Circovirosis and/or
other sanitary challenges.
Parameters Evaluated• Initial weight
• Average age
• Final weight
• Average age in the end of the trial
• Weight gain in the total period
• Feed intake
• Feed efficiency (FCR)
• EPEF
• Evaluation of antibiotic program
• E. coli investigation: Antibiogram for pathogenic E. coli
• Drug program costs
TreatmentsThree groups were used in the evaluation:
1- Control: finishing pigs (3 months before starting use of Actigen™)
2- Actigen™ partial – finishing pigs (3 months after starting Actigen™)
3- Actigen™ – finishing pigs (4 to 7 months after starting Actigen™)
Conclusions1. In 7 months Actigen™ was associated with higher sensitivity of E. coli to antibiotics with no
changes in the management program
2. ROI per animal with Actigen™ was 6:1
3. Net profits = + $4,086.00
4. Antibiotic revitalization for E. coli
5. Better ADG and EFPF
0
10
20
30
40
50
60
70
80
90
100
BEFORE AFTER
Graphic 4: E. coli sensitivity to collistin sulfatein response to dietary ActigenTM
0102030405060708090
100
AFTERBEFORE
Graphic 1: E. coli sensitivity to enrofloxacinin response to dietary ActigenTM
TABLE 2 - PERIOD EVALUATED PERFORMANCE RESULTS FOR ALL THE PRODUCTION UNITS (UPLS FROM COOPERATIVE AND PIG FARMERS)
AVERAGE RESULTS OF THE UNITS DIFFERENCECONTROL ACTIGEN
ADG, g/day 0.796 0.835 +0.039 g/dayMORTALITY 2.35 2.47 +0.12%FCR 2.70 2.67 -0.03ADJUSTED FCR 2.552 2.569 +0.017EFPF 291.33 307.50 +16.17FEED INTAKE, kg 255.15 256.91 1.76
0
50
100
AFTERBEFORE
Graphic 2: E. coli sensitivity to ceftiofourin response to dietary ActigenTM
0102030405060708090
100
AFTERBEFORE
Graphic 3: E. coli sensitivity to spectinomycinin response to dietary ActigenTM
TABLE 1: TOTAL ANTIBIOGRAM ANALYSIS WITHOUT AND WITH ACTIGEN BEFORE AFTER BEFORE AFTER BEFORE AFTER
RESISTANT INTERMIDIATED SENSITIVE
COLISTIN SULPHATE 95 18 5 3 0 78
TETRACYCLIN 100 100 0 0 0 0
DOXACYCLIN 100 95 0 5 0 0
FORPHENICOL 98 80 2 3 0 17
ENROFLOXACIN 87 18 13 5 0 77
CEFTIOFOUR 78 0 8 0 15 100
ENRITOMYCIN 100 20 0 80 0 0
LINCOMYCIN 100 100 0 0 0 0
SPECTINOMYCIN 78 3 18 3 5 95 Source: UFRGS. Not published
IntroductionSwine diets are often supplemented with
minerals in excess of requirements despite
the fact that excess minerals in manure can
pose a threat to environmental sustainability.
Zinc (Zn) is critical for nursery pig
performance (growth) and health (immune
function, antioxidant activity).
ObjectiveTo determine the need for Zn in nursery
pigs in response to inorganic, organic, or
combined Zn supplements.
Methods• Pigs weaned at 17 – 19 d of age allotted
to pens based on weight, sex, and litter.
• 2-phase complex nursery diet (NRC
1998, except Zn): Phase 1 ( 0 – 10 d),
Phase 2 ( 11 – 35 d)
• 10 dietary treatments: Basal diet (no
added Zn); Basal diet + Zn at 25, 50, 75,
or 100 pm as either Bioplex® Zn (Alltech
Inc.) or as ZnSO4; Basal diet + 25 ppm Zn
(Bioplex®) + 25 ppm Zn as ZnSO4
• Liver and intestinal mucosa were
sampled at weaning (6 pigs/trt), 10 d
post-weaning (12 pigs/trt), and 35 d
post-weaning (16 pigs/trt).
• Liver analyses included Mn superoxide dismutase (Mn SOD), Cu/Zn superoxide dismutase (Cu/Zn
SOD), Glutathione peroxidase (GSH-Px), Metallothionein protein (MT).
• Intestinal mucosa analyses included duodenum MT and jejunum MT.
Results• MnSOD activity was greater at 10 d than at 35 d post-weaning
(Table 1).
• GSH-Px activity was lower at 10 d than at 35 d post-weaning
(Table 2).
• MT concentration was greater in duodenum than in the jejunum
(Figures 1 and 2).
• Duodenal MT was generally greater using Bioplex® Zn (Figures
1 and 2).
• Hepatic MT concentration was greater using Bioplex® Zn than
ZnSO4 at 25 and 50 ppm (Figure 3).
• Hepatic Cu/ZnSOD activity was greater using the basal diet
compared with supplemented diets (Figure 4).
• Hepatic Cu/ZnSOD activity was lower using the combination trt
compared with the single-source trts (Figure 4).
Conclusions• Organic Zn from Bioplex® may be more effective in providing Zn for biologic functions
compared with Zn sulfate.
• A minimum of 75 ppm Zn should be added to a complex nursery diet in pigs.
Bioplex® and inorganic Zn effects on antioxidant enzymes and metallothionein in nursery pigs������/��������"��)��0����!����������������1Michigan State University; 2The Ohio State University
Table 1. Hepatic MnSOD in response to Zn dietary supplementation in nursery pigs.
Dietary concentration
0 ppm 25 ppm 50 ppm 75 ppm 100 ppm 50 ppm
Days post-weaning n Basal Bioplex® ZnSO4 Bioplex® ZnSO4 Bioplex® ZnSO4 Bioplex® ZnSO4
Bioplex® + ZnSO4
10 12 3.88 4.75 4.72 4.32 4.04 4.39 4.30 4.72 4.64 4.29
35 16 4.27 3.55 3.63 3.71 3.79 3.78 3.61 3.64 3.46 3.66
P-value <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
Table 2. Hepatic GSH-Px in response to Zn dietary supplementation in nursery pigs.
Dietary concentration
0 ppm 25 ppm 50 ppm 75 ppm 100 ppm 50 ppm
Days post-weaning n Basal Bioplex® ZnSO4 Bioplex ZnSO4 Bioplex® ZnSO4 Bioplex® ZnSO4
Bioplex® + ZnSO4
10 12 1.08 1.28 1.39 1.04 1.23 1.22 1.01 0.99 1.16 1.11
35 16 1.72 1.58 1.56 1.66 1.87 1.69 1.55 1.84 1.76 1.78
P-value <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
Figure 1. Duodenum and jejunum MT in nursery pigs 10 d post-weaning in response to Zn supplementation.
'�
�'�
�'�
�'�
8'�
�'�
�'�
7'�
@��>)1��� �����
@��>)1��� �����
'�
��
�'�
���
�'�
���
�'����������������
������ � �
������
�����������
������
�����������
������
�����������
�������
������������
�����������������
Duodenum Jejunum
Figure 2. Duodenum and jejunum MT in nursery pigs 35 d post-weaning in response to Zn supplementation.
@��>)1��� �����
@��>)1��� �����
���������������
������ � �
������
�����������
������
�����������
������
�����������
�������
������������
�����������������
��
���
���
���
���
��
���
.��
��
�
���
��
���
��
���
JejunumDuodenum
Figure 3. Hepatic MT in nursery pigs fed Bioplex or inorganic Zn at varied concentrations.
��
����
����
����
���
�����
�����
=)$�,�1��0��*�0>�)1�1+�=)$),� ?1���&&%�=��&,���?1�?1���&&%�6*�%��1�*+)1�"�?1� ?1���&&%�=��&,���?1�?1���&&%�6*�%��1�*+)1�"�?1� ?1�.�&&%�=��&,���?1�?1�.�&&%�6*�%��1�*+)1�"�?1� ?1�����&&%�=��&,���?1�?1�����&&%�6*�%��1�*+)1�"�?1� ?1���&&%�=��&,���?1�)1<���&&%��1�*+)1�"�?1�
@��>)1��� �����
Figure 4. Hepatic Cu/Zn SOD in nursery pigs fed Bioplex or inorganic Zn at varied concentrations.
��
���
���
���
���
��
���
.��*�1G�
��;"��1$������� ��
=)$�,�1��0��*�0>�)1�1+�=)$),� ?1���&&%�=��&,���?1�?1���&&%�6*�%��1�*+)1�"�?1� ?1���&&%�=��&,���?1�?1���&&%�6*�%��1�*+)1�"�?1� ?1�.�&&%�=��&,���?1�?1�.�&&%�6*�%��1�*+)1�"�?1� ?1�����&&%�=��&,���?1�?1�����&&%�6*�%��1�*+)1�"�?1� ?1���&&%�=��&,���?1�)1<���&&%��1�*+)1�"�?1�
������ ���� ���!�"#�#�"��$�%����&��!'��#�� ���!�"#�#�"� ����������� ()�� ���!�"#�#�"��$�%�����
Use of Actigen™ – Performance, Salmonella control and antimicrobial revitalizationDRA. GERTRUDES CORÇÃO¹, ALESSANDRA ALVES DE PAULO², MELISSA ISABEL HANNAS², ANDERSON A. DA VEIGA²¹UFRGS, ALTECH BRAZIL²
Proposal
The aim of the study was to control secondary bacterial growth in swine during growing
and finisher phase, through the synergistic effect with the use of an antibiotic and Actigen™,
minimizing the effects of the secondary diseases which can be increased by Circovirosis and/or
other sanitary challenges.
Parameters Evaluated
- Initial weight
- Average age
- Final weight
- Average age in the end of the trial
- Weight gain in the total period
- Feed intake
- Feed conversion rate (FCR)
- Mortality
- EFPF (European Feed Production Factor)
- Evaluation of antibiotic program
- Salmonella investigation
- Antibiogram for Salmonella
- Drug program costs
- 3,040 piglets in the trial in 6 pig farms
Treatments
Three groups were used in the evaluation:
1- Control: finishing pigs (3 months before starting the use of Actigen™)
2- Actigen™ partial – finishing pigs (3 months after starting the use of Actigen™)
3- Actigen™ – finishing pigs (4 to 7 months after starting the use of Actigen™)
Conclusions
• 26 strains of Salmonella were isolated in the beginning of the trial and only one was isolated
at the end of the trial.
• Actigen™ could reverse the antibiotic resistance with no changes in management in a
period of only seven months.
• ROI per animal with Actigen™ was 6:1
• Net profits = + $4,086.00
• Antibiotic revitalization for Salmonella
• Better daily gain and EFPF
0
50
100
BEFORE
AFTER
Graphic 1: Salmonella sensitivity to colistin sulphate in response to dietary ActigenTM
0
10
20
30
40
50
60
70
80
90
100
AFTER
BEFORE
Graphic 2: Salmonella sensitivity to enrofloxacin in response to dietary ActigenTM
0
50
100
AFTERBEFORE
Graphic 3: Salmonella sensitivity to ceftiofour in response to dietary ActigenTM
0
20
40
60
80
100
120
AFTER
BEFORE
Graphic 4: Salmonella sensitivity to spectinomycin in response to dietary ActigenTM
TABLE 1: TOTAL ANTIBIOGRAM ANALYSIS WITHOUT AND WITH ACTIGENTM
ANTIBIOTIC BEFORE AFTER BEFORE AFTER BEFORE AFTER
RESISTANT INTERMEDIATE SENSITIVE
COLISTIN SULPHATE 100 0 0 0 0 100
TETRACYCLIN 100 0 0 0 0 ND
DOXACYCLIN 92 0 8 0 0 0
FORFENICOL 92 0 8 0 0 0
ENROFLOXACIN 81 0 0 0 14 100
CEFTIOFOUR 100 0 0 0 0 100
ENRITOMYCIN 100 0 0 0 0 0
LINCOMYCIN 100 0 0 0 0 0
SPECTINOMYCIN 92 0 0 0 9 100 Source: UFRGS. Not published
TABLE 2 - PERIOD EVALUATED PERFORMANCE RESULTS FOR ALL THE PRODUCTION UNITS (UPLS FROM COOPERATIVE AND PIG FARMERS)
AVERAGE RESULTS OF THE UNITS DIFFERENCECONTROL ACTIGEN
ADG, g/day 0.796 0.835 +0.039MORTALITY 2.35 2.47 +0.12FCR 2.70 2.67 -0.03ADJUSTED FCR 2.552 2.569 +0.017EFPF 291.33 307.50 +16.17FEED INTAKE, kg 255.15 256.91 +1.76